Immersive Virtual Environments and Wearable Haptic Devices in rehabilitation of children with neuromotor impairments: a single-blind randomized controlled crossover pilot study.


Journal

Journal of neuroengineering and rehabilitation
ISSN: 1743-0003
Titre abrégé: J Neuroeng Rehabil
Pays: England
ID NLM: 101232233

Informations de publication

Date de publication:
28 10 2020
Historique:
received: 10 12 2019
accepted: 12 10 2020
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 9 2 2021
Statut: epublish

Résumé

The past decade has seen the emergence of rehabilitation treatments using virtual reality. One of the advantages in using this technology is the potential to create positive motivation, by means of engaging environments and tasks shaped in the form of serious games. The aim of this study is to determine the efficacy of immersive Virtual Environments and weaRable hAptic devices (VERA) for rehabilitation of upper limb in children with Cerebral Palsy (CP) and Developmental Dyspraxia (DD). A two period cross-over design was adopted for determining the differences between the proposed therapy and a conventional treatment. Eight children were randomized into two groups: one group received the VERA treatment in the first period and the manual therapy in the second period, and viceversa for the other group. Children were assessed at the beginning and the end of each period through both the Nine Hole Peg Test (9-HPT, primary outcome) and Kinesiological Measurements obtained during the performing of similar tasks in a real setting scenario (secondary outcomes). All subjects, not depending from which group they come from, significantly improved in both the performance of the 9-HPT and in the parameters of the kinesiological measurements (movement error and smoothness). No statistically significant differences have been found between the two groups. These findings suggest that immersive VE and wearable haptic devices is a viable alternative to conventional therapy for improving upper extremity function in children with neuromotor impairments. Trial registration ClinicalTrials, NCT03353623. Registered 27 November 2017-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03353623.

Sections du résumé

BACKGROUND
The past decade has seen the emergence of rehabilitation treatments using virtual reality. One of the advantages in using this technology is the potential to create positive motivation, by means of engaging environments and tasks shaped in the form of serious games. The aim of this study is to determine the efficacy of immersive Virtual Environments and weaRable hAptic devices (VERA) for rehabilitation of upper limb in children with Cerebral Palsy (CP) and Developmental Dyspraxia (DD).
METHODS
A two period cross-over design was adopted for determining the differences between the proposed therapy and a conventional treatment. Eight children were randomized into two groups: one group received the VERA treatment in the first period and the manual therapy in the second period, and viceversa for the other group. Children were assessed at the beginning and the end of each period through both the Nine Hole Peg Test (9-HPT, primary outcome) and Kinesiological Measurements obtained during the performing of similar tasks in a real setting scenario (secondary outcomes).
RESULTS
All subjects, not depending from which group they come from, significantly improved in both the performance of the 9-HPT and in the parameters of the kinesiological measurements (movement error and smoothness). No statistically significant differences have been found between the two groups.
CONCLUSIONS
These findings suggest that immersive VE and wearable haptic devices is a viable alternative to conventional therapy for improving upper extremity function in children with neuromotor impairments. Trial registration ClinicalTrials, NCT03353623. Registered 27 November 2017-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03353623.

Identifiants

pubmed: 33115487
doi: 10.1186/s12984-020-00771-6
pii: 10.1186/s12984-020-00771-6
pmc: PMC7594483
doi:

Banques de données

ClinicalTrials.gov
['NCT03353623']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

144

Références

J Pediatr Rehabil Med. 2017 May 17;10(2):145-154
pubmed: 28582885
Dev Neurorehabil. 2016;19(1):64-71
pubmed: 24724587
Pediatr Phys Ther. 2015 Fall;27(3):236-41
pubmed: 26020598
J Hand Ther. 2020 Apr - Jun;33(2):220-228.e1
pubmed: 31010703
Mult Scler. 2017 Apr;23(5):711-720
pubmed: 28206826
Disabil Rehabil. 2012;34(4):337-46
pubmed: 21961441
Eur J Phys Rehabil Med. 2015 Dec;51(6):669-76
pubmed: 25653079
J Hand Ther. 2005 Jul-Sep;18(3):348-51
pubmed: 16059856
Child Care Health Dev. 2016 Mar;42(2):253-60
pubmed: 26648488
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Child Care Health Dev. 2006 Nov;32(6):613-8
pubmed: 17018038
Semin Plast Surg. 2016 Feb;30(1):14-23
pubmed: 26869859
Dev Med Child Neurol. 2002 Oct;44(10):699-705
pubmed: 12418796
Neurorehabil Neural Repair. 2015 Feb;29(2):183-92
pubmed: 25015650
Clin Rehabil. 2016 Oct;30(10):1004-1015
pubmed: 26370148
J Neurol Phys Ther. 2017 Jul;41(3):164-172
pubmed: 28628550
IEEE Int Conf Rehabil Robot. 2017 Jul;2017:1094-1099
pubmed: 28813967
J Phys Ther Sci. 2015 Jul;27(7):2151-4
pubmed: 26311943
Dev Med Child Neurol. 2017 Jun;59(6):641-646
pubmed: 28083887
J Phys Ther Sci. 2017 Apr;29(4):665-672
pubmed: 28533607
Dev Med Child Neurol. 2003 Feb;45(2):92-6
pubmed: 12578234
IEEE Trans Haptics. 2017 Jul-Sep;10(3):305-316
pubmed: 28113306
Stroke. 2010 Jul;41(7):1477-84
pubmed: 20508185
PLoS One. 2010 May 12;5(5):e10564
pubmed: 20485681
IEEE Trans Neural Syst Rehabil Eng. 2018 Jul;26(7):1469-1478
pubmed: 29985156
Rev Paul Pediatr. 2014 Dec;32(4):389-94
pubmed: 25511004
Res Dev Disabil. 2016 Dec;59:417-427
pubmed: 27736712
Brain Cogn. 2004 Feb;54(1):7-17
pubmed: 14733895
Child Care Health Dev. 2014 Mar;40(2):165-75
pubmed: 23363371
J Neurol Phys Ther. 2008 Dec;32(4):155-63
pubmed: 19265756
Clin Rehabil. 2014 Oct;28(10):1015-24
pubmed: 24849793
Disabil Rehabil. 2020 Sep;42(18):2611-2620
pubmed: 30794762
Am J Phys Med Rehabil. 2018 Mar;97(3):164-169
pubmed: 29059068
Clin Rehabil. 2012 Dec;26(12):1096-104
pubmed: 22649162
Gait Posture. 2007 Apr;25(4):493-501
pubmed: 17270446
Dev Neurorehabil. 2017 Aug;20(6):361-367
pubmed: 27846366

Auteurs

Ilaria Bortone (I)

Institute of Clinical Physiology (IFC), National Research Council (CNR), Pisa, Italy. ilariabortone@gmail.com.

Michele Barsotti (M)

PERCRO Laboratory, Scuola Superiore Sant'Anna, Pisa, Italy.

Daniele Leonardis (D)

PERCRO Laboratory, Scuola Superiore Sant'Anna, Pisa, Italy.

Alessandra Crecchi (A)

Unit of Developmental Neurorehabilitation, Maternal and Child Department, Pisa University Hospital, Pisa, Italy.

Alessandra Tozzini (A)

Unit of Developmental Neurorehabilitation, Maternal and Child Department, Pisa University Hospital, Pisa, Italy.

Luca Bonfiglio (L)

Unit of Developmental Neurorehabilitation, Maternal and Child Department, Pisa University Hospital, Pisa, Italy.

Antonio Frisoli (A)

PERCRO Laboratory, Scuola Superiore Sant'Anna, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH